{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T05:44:34Z","timestamp":1794980674295,"version":"4.9.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,4,13]],"date-time":"2023-04-13T00:00:00Z","timestamp":1681344000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,13]],"date-time":"2023-04-13T00:00:00Z","timestamp":1681344000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Chung-Ang University Research Grants","award":["2022"],"award-info":[{"award-number":["2022"]}]},{"name":"the Korea Medical Institute","award":["the research program of the Korea Medical Institute in 2022"],"award-info":[{"award-number":["the research program of the Korea Medical Institute in 2022"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>In this study, we compared the dichotomous and 5-scale grading systems for point-of-care immunoassay of tear matrix metalloproteinase (MMP)-9 in dry eye disease (DED) patients and identified the optimal dichotomous system to correlate with DED parameters. We included 167 DED patients without primary Sjogren's syndrome (pSS) (Non-SS DED) and 70 DED patients with pSS (SS DED). We graded MMP-9 expression in InflammaDry\u00ae (Quidel, San Diego, CA, USA) using a 5-scale grading system and dichotomous grading systems with four different cut-off grades (D1 to D4 systems). The only DED parameter that showed a significant correlation with the 5-scale grading method was tear osmolarity (Tosm). In both groups, subjects with positive MMP-9 had lower tear secretion and higher Tosm than those with negative MMP-9 according to the D2 dichotomous system. Tosm determined D2 positivity at cutoffs\u2009&gt;\u2009340.5 and\u2009&gt;\u2009317.5\u00a0mOsm\/L in the Non-SS DED and SS DED groups, respectively. Tear secretion\u2009&lt;\u200910.5\u00a0mm or tear break-up time\u2009&lt;\u20095.5\u00a0s stratified D2 positivity in the Non-SS DED group. In conclusion, the dichotomous grading system of InflammaDry reflects ocular surface indices better than the 5-scale grading system and may be more practical in real clinical circumstances.<\/jats:p>","DOI":"10.1038\/s41598-023-32928-3","type":"journal-article","created":{"date-parts":[[2023,4,13]],"date-time":"2023-04-13T14:42:31Z","timestamp":1681396951000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Dichotomous versus 5-scale grading system for the interpretation of the point-of-care immunoassay for tear matrix metalloproteinase-9 in dry eye"],"prefix":"10.1038","volume":"13","author":[{"given":"Ja Young","family":"Oh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeoun Sook","family":"Chun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoung Woo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,13]]},"reference":[{"key":"32928_CR1","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.jtos.2017.05.011","volume":"15","author":"AJ Bron","year":"2017","unstructured":"Bron, A. J. et al. TFOS DEWS II pathophysiology report. Ocul. Surf. 15, 438\u2013510 (2017).","journal-title":"Ocul. Surf."},{"key":"32928_CR2","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1167\/iovs.14-14831","volume":"56","author":"R Shetty","year":"2015","unstructured":"Shetty, R. et al. Elevated expression of matrix metalloproteinase-9 and inflammatory cytokines in keratoconus patients is inhibited by cyclosporine A. Invest. Ophthalmol. Vis. Sci. 56, 738\u2013750 (2015).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"32928_CR3","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.ophtha.2014.07.048","volume":"122","author":"P Aragona","year":"2015","unstructured":"Aragona, P. et al. Matrix metalloproteinase 9 and transglutaminase 2 expression at the ocular surface in patients with different forms of dry eye disease. Ophthalmology 122, 62\u201371 (2015).","journal-title":"Ophthalmology"},{"key":"32928_CR4","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1007\/s00417-014-2708-1","volume":"252","author":"T Sakimoto","year":"2014","unstructured":"Sakimoto, T., Ohnishi, T. & Ishimori, A. Simultaneous study of matrix metalloproteinases, proinflammatory cytokines, and soluble cytokine receptors in the tears of noninfectious corneal ulcer patients. Graefes Arch. Clin. Exp. Ophthalmol. 252, 1451\u20131456 (2014).","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"32928_CR5","doi-asserted-by":"publisher","first-page":"803","DOI":"10.3109\/02713683.2013.874443","volume":"39","author":"V Horwitz","year":"2014","unstructured":"Horwitz, V. et al. The beneficial effects of doxycycline, an inhibitor of matrix metalloproteinases, on sulfur mustard-induced ocular pathologies depend on the injury stage. Curr. Eye. Res. 39, 803\u2013812 (2014).","journal-title":"Curr. Eye. Res."},{"key":"32928_CR6","doi-asserted-by":"publisher","first-page":"8285","DOI":"10.1167\/iovs.13-12235","volume":"54","author":"A Acera","year":"2013","unstructured":"Acera, A., Vecino, E. & Duran, J. A. Tear MMP-9 levels as a marker of ocular surface inflammation in conjunctivochalasis. Invest. Ophthalmol. Vis. Sci. 54, 8285\u20138291 (2013).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"32928_CR7","doi-asserted-by":"publisher","first-page":"e71948","DOI":"10.1371\/journal.pone.0071948","volume":"8","author":"A Petznick","year":"2013","unstructured":"Petznick, A., Madigan, M. C., Garrett, Q., Sweeney, D. F. & Evans, M. D. Contributions of ocular surface components to matrix-metalloproteinases (MMP)-2 and MMP-9 in feline tears following corneal epithelial wounding. PLoS ONE 8, e71948 (2013).","journal-title":"PLoS ONE"},{"key":"32928_CR8","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1177\/112067210901900504","volume":"19","author":"A Iovieno","year":"2009","unstructured":"Iovieno, A. et al. In vivo characterization of doxycycline effects on tear metalloproteinases in patients with chronic blepharitis. Eur. J. Ophthalmol. 19, 708\u2013716 (2009).","journal-title":"Eur. J. Ophthalmol."},{"key":"32928_CR9","doi-asserted-by":"publisher","first-page":"3203","DOI":"10.1167\/iovs.08-2476","volume":"50","author":"S Chotikavanich","year":"2009","unstructured":"Chotikavanich, S. et al. Production and activity of matrix metalloproteinase-9 on the ocular surface increase in dysfunctional tear syndrome. Invest. Ophthalmol. Vis. Sci. 50, 3203\u20133209 (2009).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"32928_CR10","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1001\/jamaophthalmol.2013.561","volume":"131","author":"R Sambursky","year":"2013","unstructured":"Sambursky, R. et al. Sensitivity and specificity of a point-of-care matrix metalloproteinase 9 immunoassay for diagnosing inflammation related to dry eye. JAMA Ophthalmol. 131, 24\u201328 (2013).","journal-title":"JAMA Ophthalmol."},{"key":"32928_CR11","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1097\/ICO.0000000000000175","volume":"33","author":"R Sambursky","year":"2014","unstructured":"Sambursky, R., Davitt, W. F. 3rd., Friedberg, M. & Tauber, S. Prospective, multicenter, clinical evaluation of point-of-care matrix metalloproteinase-9 test for confirming dry eye disease. Cornea 33, 812\u2013818 (2014).","journal-title":"Cornea"},{"key":"32928_CR12","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1167\/tvst.7.5.31","volume":"7","author":"JY Park","year":"2018","unstructured":"Park, J. Y., Kim, B. G., Kim, J. S. & Hwang, J. H. Matrix metalloproteinase 9 point-of-care immunoassay result predicts response to topical cyclosporine treatment in dry eye disease. Transl. Vis. Sci. Technol. 7, 31 (2018).","journal-title":"Transl. Vis. Sci. Technol."},{"key":"32928_CR13","doi-asserted-by":"publisher","first-page":"2300","DOI":"10.1016\/j.ophtha.2016.07.028","volume":"123","author":"EM Messmer","year":"2016","unstructured":"Messmer, E. M., von Lindenfels, V., Garbe, A. & Kampik, A. Matrix metalloproteinase 9 testing in dry eye disease using a commercially available point-of-care immunoassay. Ophthalmology 123, 2300\u20132308 (2016).","journal-title":"Ophthalmology"},{"key":"32928_CR14","doi-asserted-by":"publisher","first-page":"12394","DOI":"10.1038\/s41598-021-92020-6","volume":"11","author":"M Kim","year":"2021","unstructured":"Kim, M. et al. Assessment of reliability and validity of the 5-scale grading system of the point-of-care immunoassay for tear matrix metalloproteinase-9. Sci. Rep. 11, 12394 (2021).","journal-title":"Sci. Rep."},{"key":"32928_CR15","doi-asserted-by":"publisher","first-page":"759","DOI":"10.2147\/OPTH.S300047","volume":"15","author":"KJ Ryu","year":"2021","unstructured":"Ryu, K. J., Kim, S., Kim, M. K., Paik, H. J. & Kim, D. H. Short-term therapeutic effects of topical corticosteroids on refractory dry eye disease: clinical usefulness of matrix metalloproteinase 9 testing as a response prediction marker. Clin. Ophthalmol. 15, 759\u2013767 (2021).","journal-title":"Clin. Ophthalmol."},{"key":"32928_CR16","doi-asserted-by":"publisher","first-page":"e0235408","DOI":"10.1371\/journal.pone.0235408","volume":"15","author":"JH Jun","year":"2020","unstructured":"Jun, J. H., Lee, Y. H., Son, M. J. & Kim, H. Importance of tear volume for positivity of tear matrix metalloproteinase-9 immunoassay. PLoS ONE 15, e0235408 (2020).","journal-title":"PLoS ONE"},{"key":"32928_CR17","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/S0002-9440(10)62232-8","volume":"166","author":"SC Pflugfelder","year":"2005","unstructured":"Pflugfelder, S. C. et al. Matrix metalloproteinase-9 knockout confers resistance to corneal epithelial barrier disruption in experimental dry eye. Am. J. Pathol. 166, 61\u201371 (2005).","journal-title":"Am. J. Pathol."},{"key":"32928_CR18","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.exer.2006.02.004","volume":"83","author":"CS De Paiva","year":"2006","unstructured":"De Paiva, C. S. et al. Corticosteroid and doxycycline suppress MMP-9 and inflammatory cytokine expression, MAPK activation in the corneal epithelium in experimental dry eye. Exp. Eye. Res. 83, 526\u2013535 (2006).","journal-title":"Exp. Eye. Res."},{"key":"32928_CR19","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1159\/000150445","volume":"40","author":"A Acera","year":"2008","unstructured":"Acera, A., Rocha, G., Vecino, E., Lema, I. & Duran, J. A. Inflammatory markers in the tears of patients with ocular surface disease. Ophthalmic. Res. 40, 315\u2013321 (2008).","journal-title":"Ophthalmic. Res."},{"key":"32928_CR20","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.jtos.2020.10.003","volume":"19","author":"M Soifer","year":"2021","unstructured":"Soifer, M., Mousa, H. M., Stinnett, S. S., Galor, A. & Perez, V. L. Matrix metalloproteinase 9 positivity predicts long term decreased tear production. Ocul. Surf. 19, 270\u2013274 (2021).","journal-title":"Ocul. Surf."},{"key":"32928_CR21","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1006\/exer.2001.1054","volume":"73","author":"DQ Li","year":"2001","unstructured":"Li, D. Q. et al. Regulation of MMP-9 production by human corneal epithelial cells. Exp. Eye Res. 73, 449\u2013459 (2001).","journal-title":"Exp. Eye Res."},{"key":"32928_CR22","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.jtos.2017.05.008","volume":"15","author":"JP Craig","year":"2017","unstructured":"Craig, J. P. et al. TFOS DEWS II definition and classification report. Ocul. Surf. 15, 276\u2013283 (2017).","journal-title":"Ocul. Surf."},{"key":"32928_CR23","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1186\/s13075-017-1475-x","volume":"19","author":"M Le Goff","year":"2017","unstructured":"Le Goff, M. et al. Comparison of 2002 AECG and 2016 ACR\/EULAR classification criteria and added value of salivary gland ultrasonography in a patient cohort with suspected primary Sjogren\u2019s syndrome. Arthritis Res. Ther. 19, 269 (2017).","journal-title":"Arthritis Res. Ther."},{"key":"32928_CR24","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1001\/archophthalmol.2009.356","volume":"128","author":"KL Miller","year":"2010","unstructured":"Miller, K. L. et al. Minimal clinically important difference for the ocular surface disease index. Arch. Ophthalmol. 128, 94\u2013101 (2010).","journal-title":"Arch. Ophthalmol."},{"key":"32928_CR25","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.ajo.2017.05.022","volume":"180","author":"N Yokoi","year":"2017","unstructured":"Yokoi, N. et al. Classification of fluorescein breakup patterns: A novel method of differential diagnosis for dry eye. Am. J. Ophthalmol. 180, 72\u201385 (2017).","journal-title":"Am. J. Ophthalmol."},{"key":"32928_CR26","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.jcjo.2015.05.007","volume":"50","author":"Y Eom","year":"2015","unstructured":"Eom, Y., Lee, J. S., KeunLee, H., MyungKim, H. & SukSong, J. Comparison of conjunctival staining between lissamine green and yellow filtered fluorescein sodium. Can. J. Ophthalmol. 50, 273\u2013277 (2015).","journal-title":"Can. J. Ophthalmol."},{"key":"32928_CR27","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.ajo.2009.09.013","volume":"149","author":"JP Whitcher","year":"2010","unstructured":"Whitcher, J. P. et al. A simplified quantitative method for assessing keratoconjunctivitis sicca from the Sj\u00f6gren\u2019s Syndrome International Registry. Am. J. Ophthalmol. 149, 405\u2013415 (2010).","journal-title":"Am. J. Ophthalmol."},{"key":"32928_CR28","first-page":"221","volume":"21","author":"MA Lemp","year":"1995","unstructured":"Lemp, M. A. Report of the national eye institute\/industry workshop on clinical trials in dry eyes. CLAO J. 21, 221\u2013232 (1995).","journal-title":"CLAO J."},{"key":"32928_CR29","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.1167\/iovs.10-6997f","volume":"52","author":"A Tomlinson","year":"2011","unstructured":"Tomlinson, A. et al. The international workshop on meibomian gland dysfunction: Report of the diagnosis subcommittee. Invest. Ophthalmol. Vis. Sci. 52, 2006\u20132049 (2011).","journal-title":"Invest. Ophthalmol. Vis. Sci."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-32928-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-32928-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-32928-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,13]],"date-time":"2023-04-13T14:46:36Z","timestamp":1681397196000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-32928-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,13]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["32928"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-32928-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,13]]},"assertion":[{"value":"15 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6085"}}